All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.

More information on our cookie policy.

  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • Market intelligence reports
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, December 10, 2019
BioWorldBioWorld MedTechBioWorld Asia

BioWorld

  • Ash-sickle-cell-disease-12-10

    ‘Multiple ways’ of fighting once-incurable sickle cell disease

    ORLANDO, Fla. – At the 61st American Society of Hematology (ASH) annual meeting late-breaking abstracts session on Tuesday, researchers from Boston Children’s Hospital...
  • Sanofi's sutimlimab delivers benefit for CAD patients in phase III study

  • With reduced toxicity, can HSCT make it to Hall of Fame?

  • In all Candor, Darzalex has positive data

  • Summit raising $50M, gaining majority stakeholder and dropping AIM listing

  • Equillium tell: Fast track for itolizumab shows FDA faith that CD6 targeter could hit mark in lupus nephritis

  • Australia’s R&D tax incentive threatened yet again

  • Immunos raises $15M for multitasking immune-activating agents

  • Lyndra drug delivery tech for a once-monthly birth control pill tested in animals

More in BioWorld

BioWorld MedTech

  • Orthopedic-imaging-spine-hip-diagnostic

    FDA gives nod for Orthogrid’s intraoperable PhantomMSK Trauma application

    Orthogrid Systems Inc., of Salt Lake City, has received a green light from the U.S. FDA for the latest application on its intraoperable PhantomMSK platform, this one for...
  • Imperative Care gets $85M to market aspiration-based devices to treat a broader range of stroke

  • Prerevenue med-tech Venus raises $308M on HKEX

  • DC district court hands FDA a product jurisdiction loss in barium sulfate suit

  • Synaptive Medical announces close of $25M preferred share financing to expand global footprint

  • With reduced toxicity, can HSCT make it to Hall of Fame?

  • Bioworld MedTech’s Oncology Extra for Dec. 10, 2019

  • Lantheus expands microbubble, cancer applications with Carthera collaboration

  • Novel technologies may drive tighter controls for ethylene oxide sterilization

  • Advanced Oncotherapy readies first linear proton beam accelerator system for debut

More in BioWorld MedTech

BioWorld Asia

  • Rd-money1

    Australia’s R&D tax incentive threatened yet again

    PERTH, Australia – Despite a Senate inquiry recommendation to hold off on introducing cuts to Australia’s Research and Development Tax Incentive (RDTI), a bill that...
  • Luye Pharma bids to acquires Boan in $205M deal to compete in biologics

  • Emphasizing synergy and efficiency, EOC Pharma raises $71M series C to fight breast, gastric cancers

  • New PCa treatment strategy may overcome resistance

  • With another $26M, Japan’s Heartseed aims to advance iPSC-derived regenerative medicine for heart failure

  • Rapt licenses FLX-475 to Hanmi in deal worth up to $118M

  • China’s Clover completes $43M series B

  • South Korea’s Avixgen secures ₩10.6 billion in pre-IPO investment

  • Alteogen licenses ALT-B4 to a top 10 global pharma in potential $1B+ deal

  • Celltrion’s Remsima SC wins marketing approval in EU

More in BioWorld Asia
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Archives
    • Contact us
    • Cookie policy
    • Copyright notice
    • Privacy policy
    • Share your news
    • Staff
    • Terms of use
Follow Us

Copyright ©2019. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing